Related references
Note: Only part of the references are listed.Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
Laura Giuseppina Di Pasqua et al.
BIOMEDICINES (2022)
Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats
Ruben Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
Indu G. Rajapaksha et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content
Jean-Mathieu Berger et al.
MOLECULES AND CELLS (2021)
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
Lucia Barbier-Torres et al.
NATURE COMMUNICATIONS (2020)
Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
Xiaojun Ge et al.
BMJ Open (2020)
Molecular and cellular regulation of human glucokinase
Shawn M. Sternisha et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
Birgit Knebel et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
Varman T. Samuel et al.
CELL METABOLISM (2018)
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
David Hojland Ipsen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats
Ruben Rodriguez et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance
Jing Yu et al.
NUTRITION & DIABETES (2018)
Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats
Max Thorwald et al.
REDOX BIOLOGY (2018)
Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats
Ruben Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Long-term effects of angiotensin-(1-7) on lipid metabolism in the adipose tissue and liver
Carolina Campos Lima Moreira et al.
PEPTIDES (2017)
Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies
Valeria Burghi et al.
PLOS ONE (2017)
Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis
Hatem M. Abuohashish et al.
SCIENTIFIC REPORTS (2017)
Statistical data preparation: management of missing values and outliers
Sang Kyu Kwak et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2017)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
The Angiotensin-(1-7)/Mas Axis Improves Pancreatic β-Cell Function in Vitro and in Vivo
Anika Sahr et al.
ENDOCRINOLOGY (2016)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Altered Hepatic Gene Expression in Nonalcoholic Fatty Liver Disease Is Associated With Lower Hepatic n-3 and n-6 Polyunsaturated Fatty Acids
Bianca M. Arendt et al.
HEPATOLOGY (2015)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance
Xi Cao et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang et al.
NATURE REVIEWS CARDIOLOGY (2014)
Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo
Omar Echeverria-Rodriguez et al.
PEPTIDES (2014)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
The role of angiotensin II in nonalcoholic steatohepatitis
E. Matthew Morris et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
Yi-Sun Song et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7)
Victor Bilman et al.
PEPTIDES (2012)
The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli
Marco Fabricio Dias-Peixoto et al.
PEPTIDES (2012)
Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet
Sergio Henrique S. Santos et al.
REGULATORY PEPTIDES (2012)
Negative Feedback and Adaptive Resistance to the Targeted Therapy of Cancer
Sarat Chandarlapaty
CANCER DISCOVERY (2012)
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats
Kosuke Kaji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Pleiotropic Effects of ARB in Metabolic Syndrome
Satoru Yamada
CURRENT VASCULAR PHARMACOLOGY (2011)
Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis
Vijayakumar Sukumaran et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Hepatic Glucokinase Expression Is Associated with Lipogenesis and Fatty Liver in Humans
Andreas Peter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Shin-ichiro Miura et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
Sergio Henrique S. Santos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Irbesartan treatment up-regulates hepatic expression of PPARα and its target genes in obese Koletsky (fak/fak) rats: a link to amelioration of hypertriglyceridaemia
X. Rong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The renin angiotensin system and the metabolic syndrome
Annette D. de Kloet et al.
PHYSIOLOGY & BEHAVIOR (2010)
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
John S. Lubel et al.
CLINICAL SCIENCE (2009)
Specific Role for Acyl CoA:Diacylglycerol Acyltransferase 1 (Dgat1) in Hepatic Steatosis Due to Exogenous Fatty Acids
Claudio J. Villanueva et al.
HEPATOLOGY (2009)
Hepatic triacylglycerol accumulation and insulin resistance
Cynthia A. Nagle et al.
JOURNAL OF LIPID RESEARCH (2009)
A Theoretical Framework for Estimation of AUCs in Complete and Incomplete Sampling Designs
Thomas Jaki et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2009)
Fatty acid oxidation and insulin action - When less is more
Deborah M. Muoio et al.
DIABETES (2008)
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
Yongzhong Wei et al.
JOURNAL OF HEPATOLOGY (2008)
DGAT enzymes and triacylglycerol biosynthesis
Chi-Liang Eric Yen et al.
JOURNAL OF LIPID RESEARCH (2008)
Unraveling the obesity of OLETF rats
Timothy H. Moran
PHYSIOLOGY & BEHAVIOR (2008)
A place in our hearts for the lowly angiotensin 1-7 peptide?
TL Reudelhuber
HYPERTENSION (2006)
Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate
Harvey J. Motulsky et al.
BMC BIOINFORMATICS (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats
J Ran et al.
JOURNAL OF HYPERTENSION (2005)
Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats
JM Ran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats
JM Ran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats -: Role of peroxisome proliferator-activated receptor-γ
QN Diep et al.
CIRCULATION (2002)
Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension
M Hanefeld et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2001)
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
JB Dixon et al.
GASTROENTEROLOGY (2001)
Share Paper
